Literature DB >> 16252023

Use of PET/CT scanning in cancer patients: technical and practical considerations.

Landis K Griffeth1.   

Abstract

This overview of the oncologic applications of positron emission tomography (PET) focuses on the technical aspects and clinical applications of a newer technique: the combination of a PET scanner and a computed tomography (CT) scanner in a single (PET/CT) device. Examples illustrate how PET/CT contributes to patient care and improves upon the previous state-of-the-art method of comparing a PET scan with a separate CT scan. Finally, the author presents some of the results from studies of PET/CT imaging that are beginning to appear in the literature.

Entities:  

Year:  2005        PMID： 16252023      PMCID： PMC1255942          DOI： 10.1080/08998280.2005.11928089

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  12 in total

1.  [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.

Authors:  Marcelo Mamede; Tatsuya Higashi; Masanori Kitaichi; Koichi Ishizu; Takayoshi Ishimori; Yuji Nakamoto; Kazuhiro Yanagihara; Mio Li; Fumihiro Tanaka; Hiromi Wada; Toshiaki Manabe; Tsuneo Saga
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience.

Authors:  Andreas Gutzeit; Gerald Antoch; Hilmar Kühl; Thomas Egelhof; Markus Fischer; Elke Hauth; Susanne Goehde; Andreas Bockisch; Jörg Debatin; Lutz Freudenberg
Journal:  Radiology       Date:  2004-11-24       Impact factor: 11.105

3.  A combined PET/CT scanner for clinical oncology.

Authors:  T Beyer; D W Townsend; T Brun; P E Kinahan; M Charron; R Roddy; J Jerin; J Young; L Byars; R Nutt
Journal:  J Nucl Med       Date:  2000-08       Impact factor: 10.057

4.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Authors:  Gerald Antoch; Nina Saoudi; Hilmar Kuehl; Gerlinde Dahmen; Stefan P Mueller; Thomas Beyer; Andreas Bockisch; Jörg F Debatin; Lutz S Freudenberg
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

5.  Non-small cell lung cancer: dual-modality PET/CT in preoperative staging.

Authors:  Gerald Antoch; Jörg Stattaus; Andre T Nemat; Simone Marnitz; Thomas Beyer; Hilmar Kuehl; Andreas Bockisch; Jörg F Debatin; Lutz S Freudenberg
Journal:  Radiology       Date:  2003-09-25       Impact factor: 11.105

6.  Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection.

Authors:  Einat Even-Sapir; Yoav Parag; Hedva Lerman; Mordechai Gutman; Charles Levine; Micha Rabau; Arie Figer; Ur Metser
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

7.  PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.

Authors:  Zohar Keidar; Nissim Haim; Luda Guralnik; Mirjana Wollner; Rachel Bar-Shalom; Alon Ben-Nun; Ora Israel
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

8.  Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma.

Authors:  Christian Cohade; Medhat Osman; Jeffrey Leal; Richard L Wahl
Journal:  J Nucl Med       Date:  2003-11       Impact factor: 10.057

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management.

Authors:  Rachel Bar-Shalom; Nikolai Yefremov; Ludmila Guralnik; Diana Gaitini; Alex Frenkel; Abraham Kuten; Hernan Altman; Zohar Keidar; Ora Israel
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057
View more
  43 in total

1.  Automatic detection and classification of nasopharyngeal carcinoma on PET/CT with support vector machine.

Authors:  Bangxian Wu; Pek-Lan Khong; Tao Chan
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-01-04       Impact factor: 2.924

Review 2.  Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.

Authors:  Jawad Fares; Deepak Kanojia; Aida Rashidi; Atique U Ahmed; Irina V Balyasnikova; Maciej S Lesniak
Journal:  Clin Breast Cancer       Date:  2019-06-05       Impact factor: 3.225

3.  Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.

Authors:  Chung Yao Yu; Bhushan Desai; Lingyun Ji; Susan Groshen; Hossein Jadvar
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-09-06

Review 4.  [Lesions of the oral mucosa : Differential diagnostic approach from the maxillofacial surgeon's perspective].

Authors:  C Steiner
Journal:  Hautarzt       Date:  2016-10       Impact factor: 0.751

Review 5.  Potential of PET-MRI for imaging of non-oncologic musculoskeletal disease.

Authors:  Feliks Kogan; Audrey P Fan; Garry E Gold
Journal:  Quant Imaging Med Surg       Date:  2016-12

Review 6.  Applications of PET-Computed Tomography-Magnetic Resonance in the Management of Benign Musculoskeletal Disorders.

Authors:  James S Yoder; Feliks Kogan; Garry E Gold
Journal:  PET Clin       Date:  2019-01

Review 7.  Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.

Authors:  Christopher G England; Lixin Rui; Weibo Cai
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-11-14       Impact factor: 9.236

Review 8.  Imaging to study solid tumour origin and progression: lessons from research and clinical oncology.

Authors:  Stefania Raimondo; Giovanni Zito
Journal:  Immunol Cell Biol       Date:  2017-03-15       Impact factor: 5.126

9.  Genetically modified bacteria as a tool to detect microscopic solid tumor masses with triggered release of a recombinant biomarker.

Authors:  Jan T Panteli; Brittany A Forkus; Nele Van Dessel; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2015-04       Impact factor: 2.192

Review 10.  PET-MRI for the Study of Metabolic Bone Disease.

Authors:  James S Yoder; Feliks Kogan; Garry E Gold
Journal:  Curr Osteoporos Rep       Date:  2018-12       Impact factor: 5.096
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.